Diffuse mesothelioma of the peritoneum: correlation between histological and clinical parameters and survival in 73

Sandy Liu1, Paul Staats, Michael Lee

  • 1University of Maryland Medical Center, Baltimore, MD, United States.

Pathology
|November 14, 2014
PubMed

Insights

Diffuse peritoneal mesotheliomas (DPM) survival varies by subtype and invasion depth. Sarcomatoid features, deep invasion, and inflammatory stroma indicate poor prognosis in DPM patients.

Area of Science:

  • Oncology
  • Surgical Pathology
  • Cancer Research

Background:

  • Diffuse peritoneal mesotheliomas (DPM) have limited survival data.
  • Understanding prognostic factors is crucial for patient management.

Purpose of the Study:

  • To analyze survival data for diffuse peritoneal mesotheliomas (DPM).
  • To identify clinicopathological factors influencing DPM patient survival.

Main Methods:

  • Retrospective analysis of survival data from 73 DPM patients.
  • Classification of mesotheliomas by subtype, invasion grade, Peritoneal Cancer Index (PCI), and completeness of cytoreduction (CCR).

Main Results:

  • No deaths observed in well-differentiated papillary (WDPM) or multicystic (MCM) mesotheliomas with grade ≤1 invasion.
  • Overall survival decreased significantly with increasing invasion, sarcomatoid features, and inflammatory stroma.
  • Multivariate analysis identified sarcomatoid growth, depth of invasion, incomplete CCR, and inflammatory stroma as significant negative prognostic indicators.

Conclusions:

  • DPM represent a spectrum of tumors from indolent to aggressive.
  • Solid epithelioid/deciduoid tumors have an intermediate prognosis.
  • Invasion depth, sarcomatoid features, and inflammatory stroma are key poor prognostic indicators for DPM.

Related Concept Videos